Trademarkia Logo

Canada

C$
visisure
ADVERTISED

on 4 Dec 2024

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2218176 filed on 2th Jun 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

visisure

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely infections of the central nervous system, diseases Read More

Vienna Information


24 . 17 . 20

Check signsCoches, signes de validation

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 2

Letters written in double outlineLettres avec un contour double

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely infections of the central nervous system, diseases of the brain, movement disorders of the central nervous system, disorders of ocular motility, diseases of the spinal cord; pharmaceutical preparations for the prevention and treatment of immunological diseases, namely autoimmune diseases, immune deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, neck injuries cartilage; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, pelvic inflammations; pharmaceutical preparations used in dermatology, namely dermatitis, diseases affecting skin pigmentation, sexually transmitted diseases; pharmaceutical preparations used in oncology; pharmaceutical preparations used in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used for tissue and organ transplantation; pharmaceutical preparations used in ophthalmology; pharmaceutical preparations used in gastroenterology; pharmaceutical preparations for the prevention and treatment of eye disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Class [010]
Drug delivery devices for administration of pharmaceutical preparations, namely syringes for injections sold empty.


Classification kind code

11

Mark Details


Serial Number

2218176

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 3rd Jan 2024
Agent Changed
Submitted for opposition 22
on 12th Dec 2023
Search Recorded
Submitted for opposition 20
on 12th Dec 2023
Examiner's First Report
Submitted for opposition 223
on 12th Dec 2023
Total Provisional Refusal
Submitted for opposition 256
on 28th Aug 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 27th Oct 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 27th Oct 2022
Formalized
Submitted for opposition 1
on 26th Oct 2022
Created
Submitted for opposition 228
on 2th Jun 2022
International Registration
Submitted for opposition 30
on 2th Jun 2022
Filed